BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,486,715,000 | +171.2% | 36,295 | +161.4% | 0.01% | +200.0% |
| Q2 2022 | $2,023,038,000 | +202.4% | 13,884 | +146.1% | 0.00% | +200.0% |
| Q1 2022 | $668,972,000 | -64.0% | 5,642 | -58.2% | 0.00% | -66.7% |
| Q4 2021 | $1,859,470,000 | +19.4% | 13,493 | +20.3% | 0.00% | +50.0% |
| Q3 2021 | $1,557,459,000 | +706.6% | 11,212 | +463.7% | 0.00% | – |
| Q2 2021 | $193,092,000 | -53.9% | 1,989 | -67.6% | 0.00% | -100.0% |
| Q1 2021 | $419,259,000 | -32.8% | 6,134 | -15.7% | 0.00% | 0.0% |
| Q4 2020 | $623,969,000 | -14.9% | 7,280 | -35.5% | 0.00% | 0.0% |
| Q3 2020 | $733,573,000 | +144.7% | 11,284 | +175.2% | 0.00% | 0.0% |
| Q2 2020 | $299,824,000 | -79.8% | 4,101 | -90.6% | 0.00% | -66.7% |
| Q1 2020 | $1,487,826,000 | +456.5% | 43,721 | +790.3% | 0.00% | – |
| Q4 2019 | $267,355,000 | +11.1% | 4,911 | -14.9% | 0.00% | – |
| Q3 2019 | $240,683,000 | +58.2% | 5,769 | +66.0% | 0.00% | – |
| Q2 2019 | $152,170,000 | -54.5% | 3,475 | -46.5% | 0.00% | -100.0% |
| Q1 2019 | $334,555,000 | +920.6% | 6,500 | +644.6% | 0.00% | – |
| Q3 2018 | $32,781,000 | -5.0% | 873 | 0.0% | 0.00% | – |
| Q2 2018 | $34,501,000 | -78.7% | 873 | -86.1% | 0.00% | – |
| Q1 2018 | $162,262,000 | +176.1% | 6,299 | +189.2% | 0.00% | – |
| Q4 2017 | $58,762,000 | +8.7% | 2,178 | +50.6% | 0.00% | – |
| Q3 2017 | $54,051,000 | +106.3% | 1,446 | +38.0% | 0.00% | – |
| Q2 2017 | $26,200,000 | – | 1,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |